Clinical Trial Update: A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery

View source ↗

Summary

A completed prospective study validating a risk scoring model for hepatic metastasis in gastric cancer patients after curative surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Hepatic Metastasis

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Predictive Cancer Model, Hepatic Metastasis | Status: COMPLETED